Susquehanna International Group
BIOR

Susquehanna International Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Susquehanna International Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,085
Closed -$55K – 13871
2023
Q4 		$68.6K Buy
+5,085
New +$82.4K ﹤0.01% 11557
2023
Q3 		– Sell
-1,706
Closed -$54.7K – 13504
2023
Q2 		$65.7K Buy
1,706
+623
+58% +$22K ﹤0.01% 11214
2023
Q1 		$30K Buy
1,083
+230
+27% +$7.8K ﹤0.01% 11908
2022
Q4 		$28.1K Sell
853
-1,053
-55% -$76.8K ﹤0.01% 11645
2022
Q3 		$231K Sell
1,906
-782
-29% -$141K ﹤0.01% 10481
2022
Q2 		$470K Sell
2,688
-1,133
-30% -$239K ﹤0.01% 8420
2022
Q1 		$1.11M Sell
3,821
-2,371
-38% -$900K ﹤0.01% 6858
2021
Q4 		$3.23M Buy
6,192
+3,057
+98% +$2.19M ﹤0.01% 4514
2021
Q3 		$1.19M Buy
3,135
+2,704
+627% +$1.16M ﹤0.01% 7091
2021
Q2 		$384K Buy
431
+357
+482% +$273K ﹤0.01% 10231
2021
Q1 		$88K Buy
+74
New +$102K ﹤0.01% 11906

Susquehanna International Group's BIOR Position: Q1 2024 in Review

Susquehanna International Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 5,085 shares — an estimated $55K sold.

Susquehanna International Group first reported a position in BIOR in Q1 2021 and held it in 11 quarters. The position peaked at $3.23M in Q4 2021. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.

  • Susquehanna International Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 5,085 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $55K.
  • Susquehanna International Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
  • Susquehanna International Group's Biora Therapeutics, Inc. Common Stock position peaked at $3.23M in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.